Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    -16.00 (-1.27%)
Bid:
1,228.00
Ask:
1,238.00
Spread: 10.00 (0.814%)
Market Cap: £568.24m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Acquisition

1 Oct 2014 07:00

RNS Number : 0900T
Cohort PLC
01 October 2014
Β 

ο»Ώ

01 October 2014

Β 

Cohort plc

("Cohort" or "the Group")

Β 

Cohort plc acquires J+S Ltd

Β 

Β 

Cohort, the independent technology group, is pleased to announce the acquisition of J+S Limited ('J+S' or 'the Company'), an independent systems and in-service support provider for the defence and offshore energy markets, from its shareholders for a cash consideration of Β£12 million.

Highlights:

Β 

Β· Total cash consideration of Β£12m, payable from Cohort's existing resources

Β· J+S provides the Group with new capabilities in defence, offered to the UK Royal Navy and other customers globally, and offshore energy

Β· J+S will be integrated into Cohort's existing subsidiary SEA

Β· Potential to offer enhanced technology solutions, support J+S's growth opportunities and to extend SEA's access to export markets

Β· Acquisition expected to be immediately earnings enhancing

Β 

Overview of J+S Ltd:

J+S is a leading UK supplier of systems and in-service support for the defence and offshore energy markets. Its principal operating site is in Barnstaple and it also has a facility in Aberdeen. Its defence products include sonar systems, torpedo launchers and a range of other naval equipment. J+S has made sales in Canada, Malaysia and the wider Asia Pacific region, with a total of 12 per cent of 2012/13 revenue coming from outside the UK. The Company expects this proportion to increase in 2013/14. Established in 1956, J+S currently employs 137 staff across its two sites.

In the year ended 30 September 2013, J+S booked orders of Β£34.9m (2012: Β£8.8m). This was a record for the Company with a particularly strong performance from its defence business. The year-end order book stood at Β£36.5m (2012: Β£15.0m). It reported an operating profit of Β£1.5m (2012: Β£1.4m) on revenue up 4.4% to Β£13.2m (2012: Β£12.6m) for the year.

J+S expects to deliver turnover of Β£14m for the year to 30 September 2014 with an operating profit of Β£1.5m and Cohort believes growth prospects for subsequent years are strong. The Company's order book at the end of September 2014 is expected to be in excess of Β£33m.

At 30 September 2013, the gross assets of J+S were Β£8.7m and the net assets Β£3.7m. J+S's executive management will remain in place following the transaction, integrated into SEA's management team under Managing Director Stephen Hill.

Background to and reasons for the acquisition:

The acquisition of J+S is in line with the Group's stated strategy to accelerate its growth by making targeted acquisitions, complementing organic growth, whether as stand-alone members of the Group or as "bolt-in" acquisitions to our existing subsidiaries. The Board believes that this strategy of investing the Group's significant cash resources (which stood at over Β£14m as at 31 August 2014) partly in acquisitions will provide enhanced returns to shareholders.

J+S meets our stated criteria for bolt-in acquisitions where we look for businesses with capabilities and/or customer relationships that are closely linked to one of our existing subsidiaries. J+S's defence capabilities and products, notably its sonar array products, well-established manufacturing capability and long-term customer support relationships, are highly complementary to SEA's. We would expect to integrate J+S fully within SEA, leading to both cost savings and benefits from shared access to markets and technologies.

J+S's established production capability will be able to meet SEA's growing needs for submarine communication and other system manufacture. SEA's expertise in certain technology areas offers the potential for enhanced product offerings. The acquisition of J+S will extend SEA's reach internationally, by building on the strong foothold J+S has in Canada, Malaysia and the wider Asia Pacific region. It also brings a growing capability in adjacent markets including offshore energy.

Terms of the acquisition:

J+S was acquired from its shareholders, comprising David Jeffries, Chairman, and a number of other former and current employees, on a cash free / debt free basis for a consideration of Β£12m. This will be paid using Cohort's existing financial resources which included over Β£14m of net cash as at 31 August 2014 (after payment of the Β£6.0m initial consideration for the MCL transaction). Cohort retains unutilised banking facilities comprising an overdraft facility of Β£7.5m.

Andrew Thomis, Chief Executive Officer of Cohort, said:

"The acquisition of J+S represents Cohort's second significant step forward in recent months, following the acquisition of MCL in July. By integrating J+S into SEA, we aim to accelerate the growth of the combined business by enhancing its product and service offerings and broadening its international reach. The transaction will consolidate SEA's position as a leading international provider of naval defence technology.

"Overall, the two acquisitions have together substantially increased the scale, breadth and reach of Cohort's portfolio and are expected to be immediately earnings enhancing. We continue to look for attractive acquisition opportunities while focusing on integrating both businesses and delivering the synergies and growth we have identified."

An analyst conference call will take place at 9.30am this morning. To register please contact MHP (0203 128 8771 or cohort@mhpc.com)

An interview on today's announcement with the CEO of Cohort PLC, Andrew Thomis, will be available at 10:30am via the following link: http://www.brrmedia.co.uk/event/127479

Β 

Ends

Β 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Β 

Simon Walther, Finance Director

Β 

Investec Bank plc

020 7597 5970

Keith Anderson / Daniel Adams

Β 

MHP Communications Limited

020 3128 8100

Reg Hoare / Vicky Watkins

Β 

Β 

NOTES TO EDITORS

Cohort plc

Β 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

Β 

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

Β 

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

Β 

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

Β 

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence, transport and offshore energy market sectors. Acquired by Cohort in October 2007.

Β 

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQUROARSVAKOUR
Date   Source Headline
5th Dec 20237:00 amRNSContract Win
1st Dec 20239:55 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSNotice of Half Year Results
6th Nov 202310:21 amRNSHolding(s) in Company
3rd Nov 202310:35 amRNSHolding(s) in Company
1st Nov 202310:03 amRNSTotal Voting Rights
19th Oct 20237:00 amRNSSHARES/AJ BELL IN-PERSON INVESTOR EVENT NEXT WEEK
16th Oct 20237:00 amRNSShares/AJ Bell Live Investor Event, October 25
13th Oct 20234:03 pmRNSDirector/PDMR Shareholding
6th Oct 20233:48 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:09 pmRNSBlock listing six monthly return
2nd Oct 20231:04 pmRNSTotal Voting Rights
29th Sep 202310:18 amRNSDirector/PDMR Shareholding
26th Sep 20235:00 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Statement & First Quarter Update
21st Sep 20233:45 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSTotal Voting Rights
30th Aug 20232:34 pmRNSDirector/PDMR Shareholding
24th Aug 20233:26 pmRNSBlock listing six monthly return
24th Aug 20232:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Aug 20237:00 amRNSContract Win
11th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20231:39 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTotal Voting Rights
2nd Jun 20238:02 amRNSTotal Voting Rights
30th May 20238:00 amRNSContract Win
26th May 20239:56 amRNSEBT Purchase of Shares
25th May 20237:00 amRNSFull Year Trading Update
22nd May 20233:15 pmRNSEBT Purchase of Shares
15th May 20233:27 pmRNSEBT Purchase of Shares
10th May 20235:56 pmRNSEBT Purchase of Shares
9th May 202311:41 amRNSHolding(s) in Company
9th May 20239:16 amRNSContract Win
2nd May 20232:47 pmRNSDirector/PDMR Shareholding
2nd May 20232:42 pmRNSEBT Purchase of Shares
2nd May 20232:36 pmRNSTotal Voting Rights
27th Apr 20239:00 amRNSContract Announcement
5th Apr 20237:00 amRNSContract Announcement
3rd Apr 202310:30 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSBlock Listing Six Monthly Return
23rd Mar 20237:00 amRNSMASS contracted to supply EW Operation Support
22nd Mar 20237:00 amRNSChess awarded contract extension
14th Mar 202310:30 amRNSDirector/PDMR Shareholding
1st Mar 202312:38 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNSRecording of Investor Presentation
24th Feb 20231:25 pmRNSBlock listing Interim Review
17th Feb 202310:13 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.